|Articles|January 6, 2023
Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling Technologies Can Improve Drug Development
Author(s)Allucent
Allucent’s Katy Moore, Pharm. D., R.Ph. President, Clinical Pharmacology Modeling and Simulation, offers insightful commentary for small and mid-sized biotechs developing scientific breakthroughs. Learn from Katy’s expertise how applying modeling and simulation can improve drug development and help bring new therapies to light.
Trending on Applied Clinical Trials Online
1
Lab Orchestration Is Not What You Think It Is
2
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
3
ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative
4
Recruitment in the Age of AI: Q&A with John Worden, Javara
5